Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,978 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

IASO206 in Patients With Relapsed/Refractory Multiple Myeloma

NCT07322159

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

NCT07319481

Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, China

View Trial Details

Not Yet Recruiting

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

NCT07316920

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Not Yet Recruiting

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

NCT07316907

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Malignancies, +13 more
Locations: Affiliated Hospital of Jiangsu University Zhenjiang, Jiangsu, China

View Trial Details

Not Yet Recruiting

Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy

NCT07310186

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma

NCT07276230

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Caregivers of Patients With Multiple Myeloma, +13 more
Locations: Hématologie clinique - Pitié-Salpêtrière Hospital (APHP) Paris, France

View Trial Details

Not Yet Recruiting

BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients

NCT07301138

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

NCT07166549

Conditions: B Cell Lymphoma, B Cell Malignancies, B-cell Leukemia, +25 more
Locations: University Hospital Basel, Division of Hematology or Medical Oncology Basel, Canton of Basel-City, Switzerland

View Trial Details

Not Yet Recruiting

Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma

NCT07299331

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

NCT07297914

Conditions: Acute Lymphoblastic Leukemia (ALL), Graft -Versus-host-disease, Graft vs Host Disease, +12 more
Locations: St'Anna Children Hospital Vienna, Austria

University Hospital Motol Prague, Czechia

Rigshopsitalet, University Hospital Copenhagen, Denmark

HUS-Yhtymae (HUS Helsinki University Hospital) Helsinki, Finland

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions